BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 31651862)

  • 21. Real-time PCR hTERT mRNA pattern in tumor core, edge, resection margin, and lymph nodes in laryngeal tumors: relation to proliferative index and impact on prognosis.
    Eissa S; Kenawy G; Moteleb FA; El-Makhzangyc AN; Nassar M
    Clin Biochem; 2005 Oct; 38(10):873-8. PubMed ID: 16095587
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Site-specific methylation of CpG nucleotides in the hTERT promoter region can control the expression of hTERT during malignant progression of colorectal carcinoma.
    Choi JH; Park SH; Park J; Park BG; Cha SJ; Kong KH; Lee KH; Park AJ
    Biochem Biophys Res Commun; 2007 Sep; 361(3):615-20. PubMed ID: 17673177
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Putative promoters within gene bodies control exon expression via TET1-mediated H3K36 methylation.
    Ma L; Muhammad T; Wang H; Du G; Sakhawat A; Wei Y; Ali Khan A; Cong X; Huang Y
    J Cell Physiol; 2020 Oct; 235(10):6711-6724. PubMed ID: 31994732
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Allelic methylation status of CpG islands on chromosome 21q in patients with Trisomy 21.
    Xia YY; Ding YB; Liu XQ; Chen XM; Cheng SQ; Li LB; Ma MF; He JL; Wang YX
    Mol Med Rep; 2014 May; 9(5):1681-8. PubMed ID: 24573226
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epigenetic inactivation of checkpoint kinase 2 gene in non-small cell lung cancer and its relationship with clinicopathological features.
    Kim DS; Kim MJ; Lee JY; Lee SM; Choi JE; Lee SY; Park JY
    Lung Cancer; 2009 Aug; 65(2):247-50. PubMed ID: 19362748
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Different effects of interferon-alpha on melanoma cell lines: a study on telomerase reverse transcriptase, telomerase activity and apoptosis.
    Maellaro E; Pacenti L; Del Bello B; Valentini MA; Mangiavacchi P; De Felice C; Rubegni P; Luzi P; Miracco C
    Br J Dermatol; 2003 Jun; 148(6):1115-24. PubMed ID: 12828737
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aberrant DNA Methylation in Keratoacanthoma.
    Nobeyama Y; Nakagawa H
    PLoS One; 2016; 11(10):e0165370. PubMed ID: 27788211
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationships among MTHFR a1298c gene polymorphisms and methylation status of Dact1 gene in transitional cell carcinomas.
    Cheng H; Lu M; Mao LJ; Wang JQ; Li W; Wen RM; Chen JC
    Asian Pac J Cancer Prev; 2012; 13(10):5069-74. PubMed ID: 23244112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DNA Methylation of Intragenic CpG Islands are Required for Differentiation from iPSC to NPC.
    Choi WY; Hwang JH; Cho AN; Lee AJ; Lee J; Jung I; Cho SW; Kim LK; Kim YJ
    Stem Cell Rev Rep; 2020 Dec; 16(6):1316-1327. PubMed ID: 32975781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methylation of the human telomerase gene CpG island.
    Dessain SK; Yu H; Reddel RR; Beijersbergen RL; Weinberg RA
    Cancer Res; 2000 Feb; 60(3):537-41. PubMed ID: 10676632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. hTERT promoter methylation status in peripheral blood leukocytes as a molecular marker of head and neck cancer progression.
    Sobecka A; Blaszczak W; Barczak W; Golusinski P; Rubis B; Masternak MM; Suchorska WM; Golusinski W
    J Appl Genet; 2018 Nov; 59(4):453-461. PubMed ID: 30088231
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aberrant CpG methylation of the TFAP2A gene constitutes a mechanism for loss of TFAP2A expression in human metastatic melanoma.
    Hallberg AR; Vorrink SU; Hudachek DR; Cramer-Morales K; Milhem MM; Cornell RA; Domann FE
    Epigenetics; 2014 Dec; 9(12):1641-7. PubMed ID: 25625848
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Promoter methylation and expression of TIMP3 gene in gastric cancer.
    Guan Z; Zhang J; Song S; Dai D
    Diagn Pathol; 2013 Jul; 8():110. PubMed ID: 23819566
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Relationship between human telomerase reverse transcriptase transcriptional level and telomerase activity in three ovarian cancer cell lines].
    Song Y; Kong BH; Liu PS; Ma DX; Jiang S
    Ai Zheng; 2003 May; 22(5):486-91. PubMed ID: 12753708
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA hypomethylation at the CpG island is involved in aberrant expression of the L1 cell adhesion molecule gene in colorectal cancer.
    Kato K; Maesawa C; Itabashi T; Fujisawa K; Otsuka K; Kanno S; Tada H; Tatemichi Y; Kotani K; Oikawa H; Sugai T; Wakabayashi G; Masuda T
    Int J Oncol; 2009 Sep; 35(3):467-76. PubMed ID: 19639167
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subtelomeric demethylation deregulated hTERT expression, telomerase activity, and telomere length in four nasopharyngeal carcinoma cell lines.
    Zhang ZX; Wang Y; Tao ZZ; Chen SM; Xiao BK; Zhou T
    Cancer Biother Radiopharm; 2014 Sep; 29(7):289-94. PubMed ID: 25153197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prognostic significance of hTERT mRNA quantitative expression in resected gastric carcinomas].
    Qiu D; Wang WL; Zhou JJ
    Zhonghua Zhong Liu Za Zhi; 2011 Jan; 33(1):32-6. PubMed ID: 21575461
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aberrant promoter CpG island hypermethylation of the adenomatosis polyposis coli gene can serve as a good prognostic factor by affecting lymph node metastasis in squamous cell carcinoma of the esophagus.
    Kim YT; Park JY; Jeon YK; Park SJ; Song JY; Kang CH; Sung SW; Kim JH
    Dis Esophagus; 2009; 22(2):143-50. PubMed ID: 18847451
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Promoter methylation of p16, Runx3, DAPK and CHFR genes is frequent in gastric carcinoma.
    Hu SL; Kong XY; Cheng ZD; Sun YB; Shen G; Xu WP; Wu L; Xu XC; Jiang XD; Huang DB
    Tumori; 2010; 96(5):726-33. PubMed ID: 21302620
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Promoter CpG island hypermethylation in dysplastic nevus and melanoma: CLDN11 as an epigenetic biomarker for malignancy.
    Gao L; van den Hurk K; Moerkerk PTM; Goeman JJ; Beck S; Gruis NA; van den Oord JJ; Winnepenninckx VJ; van Engeland M; van Doorn R
    J Invest Dermatol; 2014 Dec; 134(12):2957-2966. PubMed ID: 24999589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.